
Exact Sciences Corporation EXAS
Geschäftsbericht 2025
hinzugefügt 13.02.2026
Exact Sciences Corporation DSO 2011-2026 | EXAS
DSO Jährlich Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.8 | 29.9 | 26.4 | 32.8 | 46.5 | 44.5 | 54.4 | 35.5 | 36.3 | 31.3 | 45.7 | 279 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 279 | 26.4 | 57.8 |
DSO Vierteljährlich Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.4 | 35.6 | 34.1 | - | 34 | 32.9 | 31.8 | - | 27.4 | 26.5 | 25.9 | - | 16.5 | 18 | 39.6 | 44.9 | 47.6 | 50.6 | 55.5 | 45.6 | 52.1 | 79.1 | 47.7 | 40.3 | 54.5 | 59.7 | 49.5 | 28.9 | 35 | 39.7 | 35.7 | 27.6 | 33.2 | 41.8 | 33 | - | - | - | - | - | 35.6 | 55.4 | 67.5 | - | 427 | 427 | 214 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 427 | 16.5 | 65.4 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
87 | $ 19.5 | 7.5 % | $ 600 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 5.76 | 11.41 % | $ 7.66 M | ||
|
Guardant Health
GH
|
46.1 | $ 133.06 | 4.75 % | $ 16.7 B | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 21.6 | 5.93 % | $ 626 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
72.7 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 23.12 | 3.63 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 152.8 | 6.18 % | $ 12 B | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
Illumina
ILMN
|
66.8 | $ 168.06 | -1.68 % | $ 26 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 102.82 | 2.56 % | $ 6.94 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 185.79 | 3.29 % | $ 9.21 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 180.48 | 0.95 % | $ 24.3 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 458.69 | 1.75 % | $ 13.2 B | ||
|
NeoGenomics
NEO
|
77.7 | $ 11.31 | 11.54 % | $ 1.45 B | ||
|
Natera
NTRA
|
48.3 | $ 222.1 | 4.84 % | $ 30.4 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.75 | 3.73 % | $ 442 M | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.69 | 6.59 % | $ 434 M | ||
|
Personalis
PSNL
|
63.8 | $ 12.1 | 12.24 % | $ 1.08 B | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 7.01 | 4.32 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.15 | 1.9 % | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 260.97 | 0.79 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 73.93 | 2.21 % | $ 4.42 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 482.03 | 1.7 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.68 | -2.4 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.12 | 3.52 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 196.12 | 1.27 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
306 | $ 376.47 | -0.87 % | $ 22.4 B |